Bone Biologics (BBLG) Return on Equity [ROE] (2022 - 2026)
Bone Biologics (BBLG) posted Return on Equity [ROE] of -55.58% for Q3 2026, up 7.25 percentage points from -62.83% a year earlier and up 6.08 percentage points from the prior quarter.
Powered by 
Analysis
Bone Biologics (BBLG) Return on Equity [ROE] (2022 - 2026) Analysis & Trends
For FY2025, Bone Biologics' Return on Equity [ROE] came in at -70.26%, up 60.05 percentage points from FY2024.
- Annual Return on Equity [ROE] shows a three-year change of -11.72 percentage points (FY2022 to FY2025).
- In prior years, Bone Biologics' Return on Equity [ROE] was -130.31% in FY2024 (+82.63 pp), -212.94% in FY2023 (-154.40 pp) and -58.54% in FY2022.
- Quarterly Return on Equity [ROE] has run from a low of -281.42% in Q4 2023 to a high of -29.60% in Q1 2022 over five years.
- The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q4 2024, with a gain of 166.98 percentage points; the weakest was Q4 2023, with a drop of 211.20 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 266.22 Bn | 242.86 Bn | 5.13 Bn | 13.20% |
| 2 | Abbott Laboratories | 191.31 Bn | 165.77 Bn | 7.39 Bn | 9.09% |
| 3 | Danaher | 166.16 Bn | 145.82 Bn | 3.84 Bn | 8.15% |
| 4 | Intuitive Surgical | 155.98 Bn | 136.40 Bn | 2.08 Bn | 17.28% |
| 5 | Medtronic | 130.05 Bn | 96.18 Bn | 6.34 Bn | 17.46% |
| 6 | Stryker | 123.40 Bn | 109.59 Bn | 4.25 Bn | -4.01% |
| 7 | Boston Scientific | 64.81 Bn | 60.48 Bn | 3.43 Bn | 13.69% |
| 8 | Edwards Lifesciences | 59.87 Bn | 43.18 Bn | 1.35 Bn | 9.36% |
| 9 | Medline | 53.84 Bn | 50.96 Bn | 1.93 Bn | 4.56% |
| 10 | Bone Biologics | 1.15 Mn | -18.84 Mn | - | -57.57% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -57.57% |
| Jun 30, 2026 | -67.32% |
| Mar 31, 2026 | -56.94% |
| Dec 31, 2025 | -54.64% |
| Sep 30, 2025 | -62.83% |
| Jun 30, 2025 | -88.89% |
| Mar 31, 2025 | -133.82% |
| Dec 31, 2024 | -114.44% |
| Sep 30, 2024 | -113.07% |
| Jun 30, 2024 | -150.00% |
| Mar 31, 2024 | -218.28% |
| Dec 31, 2023 | -281.41% |
| Sep 30, 2023 | -201.43% |
| Jun 30, 2023 | -205.38% |
| Mar 31, 2023 | -139.71% |
| Dec 31, 2022 | -70.22% |
| Sep 30, 2022 | -50.51% |
| Jun 30, 2022 | -31.18% |
| Mar 31, 2022 | -29.60% |
API Access
Bone Biologics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=BBLG&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "BBLG", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=BBLG&period=max&api_key=YOUR_API_KEY");
const data = await res.json();